NCT03574415View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

January 18, 2019

Study Completion Date

January 23, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

DWP14012

DWP14012 tablets

DRUG

Placebo

DWP14012 placebo-matching tablets

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY